Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ORGANICA Feinchemie Wolfen is a German-based Contract Development and Manufacturing Organization (CDMO) specializing in the custom synthesis of fine chemicals and pharmaceutical intermediates. Established in 1995, the company provides a broad spectrum of chemical services ranging from process development to large-scale commercial manufacturing. Their core competencies include complex multi-step syntheses, hazardous chemistry, and high-pressure reactions, particularly in the fields of heterocyclic and sulfur chemistry. As part of the International Chemical Investors Group (ICIG), ORGANICA serves the global pharmaceutical, diagnostic, and specialty chemical industries from its production site in Bitterfeld-Wolfen. The company operates under ISO 9001 standards and offers manufacturing capabilities that scale from laboratory quantities to multi-ton batches.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ORGANICA Feinchemie Wolfen.